IML presents RHA (Resilient Hyaluronic Acid)
IML presented RHA (Resilient Hyaluronic Acid), the first hyaluronic acid that maintains facial movement. The presentation, by Dr. Almudena Royo, aesthetic physician at IML and Dr. Wolfgang Redka-Swoboda, plastic surgeon and member of the RHA design team, was also attended by journalists and bloggers specialised in Beauty. The event was held at the IML headquarters on 27th May 2015.
The differential element of RHA is the conservation of the long chains of hyaluronic acid and the presence of a lower number of irreversible covalent bonds, which provides greater elasticity than other hyaluronic acid products on the market. RHA is indicated for the treatment of wrinkles in movable areas, especially in patients for whom Botulinum Toxin no longer works, as well as for volume correction in deep fat deposits.